胎儿成纤维细胞羊膜皮肤替代物促进烧伤供皮区愈合的随机双盲I期临床试验
该随机双盲I期试验纳入10例烧伤面积10-55%患者,在供皮区比较凡士林纱布、羊膜及羊膜接种胎儿成纤维细胞三种处理。结果显示羊膜组和羊膜-胎儿成纤维细胞组疼痛更低、愈合更快,但胎儿成纤维细胞相比单用羊膜无额外获益,安全性良好。
要点
- 羊膜或羊膜接种胎儿成纤维细胞均较凡士林纱布加速供皮区愈合、减轻疼痛。
- 胎儿成纤维细胞联合羊膜相比单用羊膜未见额外获益。
- 该疗法在10例患者中未观察到不良事件,安全性初步可行。
核心结论
- 羊膜接种胎儿成纤维细胞移植治疗烧伤供皮区安全性良好,但初步评估未显示优于单用羊膜。
研究设计与样本
- 随机双盲I期临床试验,纳入10例总烧伤面积10-55%的患者,每例供皮区设三个10×10cm等大区域分别接受凡士林纱布、羊膜或羊膜接种胎儿成纤维细胞处理。
主要发现
- 羊膜接种胎儿成纤维细胞组和羊膜组疼痛强度显著低于对照组,愈合率显著高于对照组。
- 羊膜接种胎儿成纤维细胞组和羊膜组平均完全再上皮化时间分别为10.1±2.4天和11.3±2.9天,显著快于对照组的14.8±1.6天。
- 组织学评估显示羊膜接种胎儿成纤维细胞组和羊膜组炎症细胞浸润低于对照组。
- 所有患者手术及随访期间未发生不良事件。
临床怎么用
- 基于初步数据,羊膜或羊膜接种胎儿成纤维细胞可作为烧伤供皮区促进愈合的潜在选项,但胎儿成纤维细胞联合羊膜未显示额外优势。
- 需开展更大样本的试验以准确评估该疗法的获益。
局限性
- 样本量小(10例),仅为I期初步评估,结论需更大规模试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Due to limited graft donor sites in extensive burns, re-harvesting of a single donor area is very common. Given the importance of fetal fibroblasts in accelerating fetal wound healing, fetal cell-based skin substitutes have emerged as a novel therapeutic modality for regenerating damaged skin. In this trial, we aimed to evaluate the safety, feasibility and potential efficacy of application of amniotic membranes seeded with fetal fibroblasts for accelerating donor sites healing in burn patients. METHODS: In this randomized, double-blind, phase I clinical trial, 10 patients with total burn surface area of 10-55% were enrolled. Three equal parts (10×10cm) were selected in donor site of each patient and covered by Vaseline gauze (control group), amniotic membrane (AM group), or amniotic membrane seeded with fetal fibroblasts (AM-F group). Adverse events, pain intensity scores, and wound sizes were recorded on days 4, 8, 11, 14, and 20 post-treatment. Also, histological assessments were done on days 0 and 14 after the surgery. RESULTS: All patients underwent surgery, and no adverse events occurred during the procedure and follow-up period. Significantly lower pain intensity and higher healing rates were observed in AM-F and AM groups compared to the control group. Moreover, mean complete re-epithelializatin in AM-F and AM groups were 10.1±2.4 and 11.3±2.9 days, showing that the healing process was significantly accelerated compared to the control group with mean closure time of 14.8±1.6 days. Histological assessment showed lower inflammatory cells infiltration in AM-F and AM groups compared to control group. CONCLUSIONS: This study indicated the safety of transplantation of amniotic membrane seeded with fetal fibroblasts for treatment of donor sites in burn patients; however, preliminary assessments showed no benefits for this therapeutic modality over amniotic membrane alone. Thus, to draw accurate conclusions, further trials in larger populations should be conducted. LEVEL OF EVIDENCE: This study is assigned as level I.
引用
- Momeni M, Fallah N, Bajouri A, et al. A randomized, double-blind, phase I clinical trial of fetal cell-based skin substitutes on healing of donor sites in burn patients. Burns. 2018. PMID: 30559055. doi:10.1016/j.burns.2018.10.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。